• David Hartell

CNTRP researchers presenting at the ATC


Here is a list of the presentations and posters by CNTRP members at the American Transplant Congress, taking place in Philapelphia from May 2-6, 2015. You can download a copy of this list here.

Saturday, May 2, 2015

Pre-Meeting Symposia

1:00 pm -5:30 pm

IMMUNE MONITORING IN THORACIC ORGAN TRANSPLANTATION

METHODS AND MECHANISMS Room 119-A

1:30 pm – 2:00 pm

Blood Biomarkers for the Detection of Rejection in Transplant Recipients

Bruce McManus, MD

ADVANCED IMMUNOLOGY UPDATES FOR BASIC AND CLINICAL SCIENTISTS

Room 122-AB

2:30 pm – 3:00 pm

Update on Tregs

Qhizi Tang, PhD

MEDICAL CARE OF THE KIDNEY TRANSPLANT RECIPIENT

KEEPING KIDNEY ALLOGRAFT ALIVE

Terrace IV

3:15 pm – 3:45 pm

Chronic AMR: Should This Diagnosis Alter Therapy?

Kathryn Tinckam, MD

BASIC IMMUNOLOGY AND TRANSPLANT IMMUNOLOGY FOR THE CLINICIAN

Room 120-ABC

3:45 pm – 4:15 pm

T Cell and B Cell Targeted Immunosuppression in Transplantation

Roslyn Mannon, MD (EAB)

EXCITING UPDATES IN TRANSPLANT ID: CASE-BASED LEARNING

WHAT ENQUIRING MINDS WANT TO KNOW

Room 119-B

4:20 pm – 4:40 pm

Vaccination of the Adult Transplant Recipient

Deepali Kumar, MD, MSc

ON YOUR TOES: RAPID FIRE CASES

Room 119-B

5:00 pm – 5:30 pm

Rapid Fire Cases

Deepali Kumar, MD, MSc

Poster Session A

5:30pm-7:30pm

Exhibit Hall E

Abstract number: 127

Neonatal Tolerance: Donor and Host Cells Fuse in Livers of Newborn Mice Injected With F1-Bone Marrow/Spleen Cells

R. Bascom, K. Tao, S. Tollenaar, L. West.

Abstract number: 341

Should We Ever Pay Living Kidney Donors? Focus Group Study of Public Opinion

A. Tong, A. Ralph, J. Chapman, G. Wong, J. Gill, M. Josephson, C. Hanson, J. Craig.

Abstract number: 1476

Late Onset Cluster of Pneumocystis Jirovecii Pneumonia (PJP) in Renal Transplant Patients: Re-Examining Prophylaxis Strategies

G. Sekhon, L. Gunaratnam, H. Iyer, J. Johnson, N. Muirhead, A. Newman, F. Rehman, M. Weir, M. Silverman, A. House, A. Jevnikar, S. Hosseini-Moghaddam.

Abstract number: 1687

The Benefit of Hepatitis C Donor Kidney Transplantation Is Limited to Hepatitis C Positive Patients Over 50 Years of Age

T. Myint, A. Wright, C. Rose, C. Kennedy, J. Dong, J. Gill, J. Gill.

Abstract number: 1749

Weight Loss, But Not Weight Gain Is a Risk Factor for Graft Loss After Kidney Transplantation

E. Hendren, J. Dong, C. Kennedy, T. Myint, C. Rose, O. Johnston, J. Gill, J. Gill.

Abstract number: 1774

Cell Type of the Tolerizing Inoculum Plays a Role in the Formation of of Molecular Chimerism in Murine Neonatal Tolerance

X. Wang, H. Mewhort, S. Wang, S. Tollenaar, K. Tao, L. West.

Abstract number: 1890

Incidence, Risk Factors, and Outcomes of Hospitalized Urinary Tract Infections in Kidney Transplant Recipients

H. Pang, C. Liang, O. Famure, Y. Li, J. Kim.

Abstract number: 1894

Validation of Predictive Nomograms for Delayed Graft Function in Kidney Transplant Recipients

L. Chau, O. Famure, J. Kim.

Abstract number: 1900

Immune-Mediated Injury in Kidney Transplant Recipients Treated With Alemtuzumab Induction and a Steroid Avoidance Protocol

R. Sapir-Pichhadze, T. Mahbub, C. Saw, D. Baran.

Sunday, May 3, 2015

Midday Symposia

11:00 am – 12:30 pm

T REGULATORY CELLS

Room 118-C

11:00 am – 11:30 am

Mouse and Human Treg Populations

Megan Levings, MD

EMERGING INSIGHTS IN VIRAL INFECTIONS AND SOLID ORGAN TRANSPLANTATION

Room 119-B

11:00 am – 11:30 am

Novel Prevention of BK: Monitoring, Cellular Assays, and Quinolones Plus Other Combination Therapies

Gregory Knoll, MD

KIDNEY TRANSPLANTATION IN THE ELDERLY

Terrace IV

11:30 am – 12:00 pm

What is the Best Type of Allograft for the Elderly Candidate?

John Gill, MD

LIVING DONATION IS SAFE: FACT OR FICTION?

Room 122-AB

12:00 pm – 12:15 pm

Medical Outcomes among Publicly and Privately Insured Living Donors

Amit Garg, MD

Transplantation in Depth

1:00 pm – 4:00 pm

THE IMPACT OF INFECTION AND TRAUMA ON THE IMMUNE SYSTEM

Room 120-ABC

3:30 pm- 4:00 pm

The Impact of Necroptosis in Tissue Inflammation

Anthony Jevnikar, MD

Concurrent Sessions

2:15pm-3:45pm

Deceased Donor Management

Room 119-A

2:27pm-2:39pm

Enhanced Production of Macrophage Chemoattractant Protein-1 (MCP-1) Within the Kidney in Brain Death Donors Predicts Recipient Allograft Function

J. Chen, S. Antipenko, A. Zmijewska, R. Reed, J. Locke, R. Mannon (EAB).

Donor-Derived Infection/Lifestyle/Tourism/Vaccines

Room 115- AB

2:51pm-3:03pm

Infections After Transplant Tourism in Organ Transplant Recipients

D. Kumar, A. Humar, H. Crossman, C. Kotton, M. Levi.

Kidney Complications: Late Graft Failure

Terrace IV

3:27pm-3:39pm

Does a History of Diabetes in Deceased Donors Modify the Outcomes of Kidney Transplant Recipients With Diabetes?

T. Rajan, J. Kim.

Concurrent Sessions

4:00pm-5:30pm

Alloantibodies and Rejection: Animal Models

Room 118-AB

4:48pm-5:00pm

Multicenter Validation of a Molecular Diagnostic for Antibody-Mediated Rejection in Formalin-Fixed Paraffin-Embedded Human Renal Allograft Biopsies

B. Adam, B. Afzali, N. Shah, K. Dominy, R. Gill, L. Hidalgo, P. Campbell, C. Roufosse, M. Mengel, B. Sis.

Economics, Policy and Ethics

Room 118-C

4:48pm-5:00pm

Survival Benefit of ECD Transplantation After Ultra-Long Dialysis Exposure: Implications for Acceptance in the New KAS

C. Kennedy, J. Dong, T. Myint, C. Rose, O. Johnston, J. Gill, J. Gill.

Kidney Antibody Mediated Rejection II

Terrace I-III

4:36pm-4:48pm

Part II: Rates and Determinants of Progression for De Novo Donor-Specific Antibody Mediated Kidney Allograft Injury

C. Wiebe, I. Gibson, D. Pochinco, P. Birk, T. Blydt-Hansen, J. Ho, M. Karpinski, A. Goldberg, L. Storsley, D. Rush, P. Nickerson.

Regulatory T Cells

Room 122-AB

4:24pm-4:36pm

Ex Vivo Expansion With Rapamycin Enhances the Suppressive Function of Regulatory T Cells (Tregs) Isolated from Pediatric Thymus

E. Dijke, R. Hoeppli, T. Ellis, J. Pearcey, I. Larsen, I. Rebeyka, D. Ross,, M. Levings, L. West.

T Cell Biology

Room 119-B

4:24pm-4:36pm

Tracking T Cell Fate After Antithymocyte Globulin (ATG) Immunotherapy in Infant Heart Transplant (HTx) Patients

S.-I. Wang, I. Larsen, S. Urschel, R. Chinnock, J. Rusch, L. West.

Poster Session B

5:30pm-6:30pm

Exhibit Hall E

Abstract number: 30

Molecular Testing for Microcirculation Injury Enhances the Assessment of Antibody-Mediated Rejection in Human Cardiac Allograft Biopsies

B. Afzali, E. Chapman, B. Adam, F. Riesgo Gil, D. Kim, L. Hidalgo, P. Campbell, B. Sis, M. Mengel.

Abstract number: 108

Age-Specific Graft Failure Rates in Pediatric Heart Transplant Recipients

B. Foster, M. Dahhou, X. Zhang, V. Dharnidharka, V. Ng, J. Conway.

Abstract number: 225

Increase in Neurologic Determination of Death (NDD) Organ Donation in the Donation After Circulatory Death (DCD) Era. The Ontario Experience

J. Zaltzman, J. MacLean, C. Payne, E. Paltser, V. Rao, S. Dhanani.

Abstract number: 554

Expanding the Donor Pool: Comparison of Outcomes in DCD Vs Living Donor Liver Transplantation

G. Sapisochin, J. Seal, N. Goldaracena, T. Reichman, J. Laurence, H. Bohorquez, I. McGilvray, D. Bruce, P. Greig, I. Carmody, M. Cattral, A. Ghanekar, D. Grant, G. Loss, M. Selzner.

Abstract number: 808

Renal Resistance Measured During Pulsatile Perfusion and Long-Term Kidney Transplant Outcomes

S. Sandal, R. Sapir-Pichhadze, M. Cantarovich, S. Paraskevas.

Abstract number: 874

The Synergistic Effect of Class II HLA Epitope-Mismatch and Non-Adherence on Acute Rejection and Graft Survival

C. Wiebe, T. Nevins, W. Robiner, W. Thomas, A. Matas, P. Nickerson.

Abstract number: 923

Six-Month Urinary CCL2 Levels Predict Long-Term Renal Allograft Outcome

J. Ho, D. Rush, A. Gao, H. Hopfer, C. Wiebe, P. Nickerson, S. Schaub, P. Hirt-Minkowski.

Abstract number: 950

Fast Track of Adult-to-Adult Live Donor Liver Transplant Recipients: Avoiding ICU Admission Reduces Complications and Post Transplant Hospital Stay

J. Echeverri, N. Goldaracena, A. Singh, G. Sapisochin, N. Selzner, M. Cattral, P. Greig, L. Lilly, I. McGilvray, G. Levy, A. Ghanekar, E. Renner, D. Grant, S. McCluskey, M. Selzner.

Abstract number: 1507

Live Donor Vs Deceased Donor Liver Transplantation Results in Identical Outcome in Recipients With Acute Liver Failure – An Important Choice for Critical Ill Patients

N. Goldaracena, G. Sapisochin, J. Echeverri, M. Kaths, N. Selzner, M. Cattral, P. Greig, L. Lilly, I. McGilvray, G. Levy, A. Ghanekar, E. Renner, D. Grant, M. Selzner.

Abstract number: 1517

Is Ex Vivo Liver Perfusion a Safe Alternative to Cold Static Storage for the Preservation of Standard Criteria Grafts?

N. Goldaracena, V. Spetzler, M. Kaths, J. Echeverri, M. Selzner.

Abstract number: 1549

Delivery of Heme Oxygenase-1-Cell Penetrating Peptide (HO-1-CPP) Into Hepatocytes, Kupffer and Islet Cells in In Vitro and Ex Vivo Models of Cold Ischemia

A. Venkatachalam, C. Wood, Q. Hu, I. Alwayn.

Abstract number: 1847

Prevalence, Risk Factors, and Clinical Management of Chronic Renal Dysfunction in Heart Transplant Recipients

K. Xhima, O. Famure, Y. Li, J. Kim.

Abstract number: 1876

The Impact of Delayed Graft Function (DGF) and Acute Rejection (AR) on the Decline in Allograft Function After Kidney Transplantation

J. Gill, J. Dong, C. Rose, J. Gill.

Abstract number: 1891

Genetic Diversity Epstein-Barr Virus Latent Gene EBNA-1 Among Transplant Patients and Patients With Infectious Mononucleosis

K. Sullivan, S. Isabel, E. Maria, P. Tara, Y. Simon, K. Nasser, N. Vicky, A. Upton.

Abstract number: 1912

Stability of Kidney Allograft Function Is Improving Over Time Across All Donor Types

J. Gill, J. Dong, C. Rose, J. Gill.

Monday, May 4, 2015

Sunrise Symposia

7:00 am – 8:15 am

ANTIBODIES IN THORACIC TRANSPLANTATION – SHEDDING NEW LIGHT ON THE SUBJECT

Room 119-A

7:25 am – 7:50 am

How Are Antibodies Measured, Quantified and Defined to be Clinically Relevant (or not)?

Kathryn Tinckam, MD

Midday Symposia

11:00 am – 12:30 pm

AUTOIMMUNITY DURING ALLOGRAFT REJECTION

Room 119-A

11:00 am – 11:30 am

Cell Death Dysregulation: A Central Trigger of Autoimmunity in Transplantation

Marie Josee Hebert, MD

KIDNEY ANTIBODY-MEDIATED REJECTION

Terrace IV

11:30 am – 12:00 pm

The High-Risk Patient: Does Monitoring AMR Improve Outcomes?

Peter Nickerson, MD

STATE-OF-THE-ART CMV PREVENTION ANDTHERAPY

Room 119-B

11:30 am – 12:00 pm

Beyond Status Quo: Novel Therapies for CMV

Atul Humar, MD, MSC

12:00 pm – 12:30 pm

Novel Immune Diagnostics: Are We There Yet?

Deepali Kumar, MD

Concurrent Sessions

2:15pm-3:45pm

Antibodies and Graft Injury: Translational

Room 121-AB

2:15pm-2:27pm

Pre-Transplant Anti-LG3 Antibodies Enhance Allograft Dysfunction in Kidney Transplant Recipients With Delayed or Slow Graft Function

H. Cardinal, M. Hénault-Rondeau, S. Morissette, K. Hamelin, M.-J. Hébert.

Immune Monitoring I

Room 120-ABC

2:15pm-2:27pm

Serum Proteins Are Significantly Upregulated in Patients With Clinical Antibody-Mediated Rejection

A. Gareau, I. Gibson, C. Wiebe, J. Ho, D. Rush, P. Nickerson.

Ischemia Reperfusion Injury: Basic Mechanisms

Room 119-A

3:03pm-3:15pm

Loss of RIPK3 and Caspase-8 Enhance Intrinsic Apoptosis in Tubular Epithelial Cell (TEC) Death and Contributes to Kidney Ischemia Reperfusion Injury (IRI)

B. Sung, Y. Su, A. Lau, J. Jiang, A. Haig, D. Green, Z. Zhang, A. Jevnikar.

Kidney: Surgical Technique/Complications

Room 115-AB

3:15pm-3:27pm

Hydrogen Sulfide Restores Protective Capacity of University of Wisconsin Solution During Normothermic Preservation

J. Grewal, I. Lobb, M. Whiteman, A. Sener.

Optimizing Immunosuppression in Pancreas Transplantation

Room 119-B

3:27pm-3:39pm

Donor Specific Antibodies (DSA) Increase the Risk for Rejection After Pancreas Transplantation Without Negatively Impacting Survival

M. Marquez, M. Dib, G. Sapisochin, J. Laurence, A. Barbas, F. Bazerbachi, A. Norgate, M. Selzner, P. Greig, I. McGilvray, M. Cattral.

Transplant Tolerance: Animal Models I

Room 121-C

3:03pm-3:15pm

Tolerance to Graft A-Antigens Following ABO-Incompatible Heart Transplantation (HTx) in a Blood Group A-Transgenic Mouse Model

B. Motyka, K. Labonte, F. Rahman, J. Pearcey, K. Tao, M. Mengel, B. Sis, P. Cowan, L. West.

Concurrent Sessions

4:00pm-5:30pm

Basic Mechanisms of Chronic Injury and Fibrosis

Room 121-C

4:36pm-4:48pm

The Forgotten Cell: Renal Fibroblasts Are Activated By Anti-MHC Class I Antibody

J. Chen, A. Zmijewska, R. Mannon (EAB).

4:48pm-5:00pm

Cyclosporine Nephrotoxicity Is Associated With Diminished Expression of Heat Shock Protein 27 (HSP27) and Loss of Claudin-2-Dependent Intercellular Adhesion

A. Zmijewska, R. Thuillier, J. Chen, J. Zmijewski, R. Mannon (EAB).

Liver Transplantation for Hepatocellular Carcinoma

Room 113-BC

4:24pm-4:36pm

The Extended Toronto Criteria for Transplantation for Hepatocellular Carcinoma. A Validation Study

G. Sapisochin, N. Goldaracena, J. Laurence, M. Dib, A. Barbas, A. Ghanekar, L. Lilly, E. Renner, M. Selzner, M. Cattral, I. McGilvray, D. Grant, P. Greig.

Viral Infections (CMV, HBV, HCV, HIV, Norovirus)

Room 121-AB

4:36pm-4:48pm

Analysis of In-Vitro Effects of Immunosuppression on NK Cell Subsets in the Presence of Cytomegalovirus

S. Keshwani, D. Kumar, S. Han, S. Husain, V. Ferreira, P. Ashton, A. Humar.

Poster Session C

5:30pm-6:30pm

Exhibit Hall E

Abstract number: 133

Optimal Management of Distal Ureteric Stricture Following Renal Transplantation: A Systematic Review

J. Kwong, D. Schiefer, G. Anas, J. Archambault, P. Luke, A. Sener.

Abstract number: 300

Heterologous Immune Responses to Influenza Vaccine in Kidney Transplant Recipients

D. Kumar, P. Campbell, K. Hoschler, A. Humar.

Abstract number: 620

The 20S Proteasome Is Active in Apoptotic Nanovesicles and Controls Anti-LG3 Antibody Production

M. Dieudé, C. Bell, J. Turgeon, D. Beillevaire, K. Hamelin, S. Qi, N. Pallet, C. Rondeau, D. Gingras, M. Desjardins, P. Thibault, M.-J. Hébert.

Abstract number: 621

Anti-LG3 Antibodies Aggravate Ischemia-Reperfusion Injury

B. Yang, K. Hamelin, L. Pomerleau, J. Peng, J. Tremblay, N. Patey, M.-J. Hébert.

Abstract number: 697

Increased Use of Donors After Cardiac Death (DCD) in Pancreas Transplantation: A Safe and Effective Way to Increase a Single Center Program Activity

M. Marquez, G. Sapisochin, J. Laurence, A. Barbas, M. Dib, A. Norgate, M. Selzner, P. Greig, I. McGilvray, M. Cattral.

Abstract number: 785

The Immunogenic Perlecan Fragment LG3 Is Released Through Apoptotic Extracellular Vesicles Downstream of Caspase-3 Activation

D. Beillevaire, J. Turgeon, D. Gingras, é. Boilard, M. Dieudé, M.-J. Hébert.

Abstract number: 889

Safety and Efficacy of Conversion from Conventional Twice Daily Tacrolimus to Once Daily Extended Release Tacrolimus in Stable Pancreas Transplant (SPK and PAK) Recipients

M. Dib, A. Barbas, M. Marquez, J. Laurence, G. Sapisochin, A. Norgate, J. Schiff, I. McGilvray, P. Greig, M. Selzner, M. Cattral.

Abstract number: 901

Assessing Pre-Vaccination Cytokine Levels to Predict Immunogenicity to Seasonal Trivalent Influenza Vaccine in Solid Organ Transplant Recipients

M. Fernandez-Ruiz, A. Humar, S. Keshwani, S. Husain, D. Kumar.

Abstract number: 1029

Prospective, 6 Month, Open Label, Conversion Study from Mycophenolate Mofetyl to Mycophenolic Acid Evaluating the Severity of Gastro-Intestinal Symptoms and Mycophenolic Acid Urinary Metabolite as a Surrogate Marker of Plasmatic Area Under the Curve

D. Tran, A. Boucher, L. Senécal, V. Pichette, F. Leblond, S. Collette.

Abstract number: 1423

B-Cell Activation in Acute Kidney Injury and Delayed Graft Function

M. Schiffer, F. Wiehler, R. Song, R. Chen, L. Schiffer, M. Mengel, H. Haller, F. Gueler

Tuesday, May 5, 2015

Sunrise Symposia

7:00 am – 8:15 am

HLA EPITOPE MATCHING: IS IT READY FOR PRIME TIME?

Room 122-AB

7:25 am – 7:50 am

Assessing Immunological Risk Post Transplantation by Quantifying Epitope Mismatches

Peter Nickerson, MD

Concurrent Sessions

2:15pm-3:45pm

Islet Transplantation: Basic

Room 121-C

3:27pm-3:39pm

Effector T Cell Migration to Pancreatic Islet Allografts Is Dependent On Donor Antigen Recognition and Not Gαi Chemokine Signaling

Q. Zhang, H. Dai, Q. Zeng, A. Williams, M. Oberbarnscheidt, F. Lakkis (EAB).

Kidney: Pregnancy, Metabolic Complications, Malignancy

Room 119-B

2:15pm-2:27pm

Timing of Pregnancy and Risk of Kidney Allograft Failure

C. Rose, O. Johnston, A. Mehrotra, C. Kennedy, T. Myint, E. Hendren, J. Gill, J. Gill.

Liver: Living Donors and Partial Grafts

Room 115-AB

3:27pm-3:39pm

Live Donor Liver Transplantation With Older (>50years) Vs Younger (<50years) Donors: Does Age Matter?

N. Goldaracena, G. Sapisochin, J. Echeverri, M. Kaths, N. Selzner, M. Cattral, P. Greig, L. Lilly, I. McGilvray, G. Levy, A. Ghanekar, E. Renner, D. Grant, M. Selzner.

PTLD and Other Malignancies

Room 122-AB

2:27pm-2:39pm

Clinical and Virologic Outcomes in High-Risk Adult EBV D+/R- Organ Transplant Recipients

D. Kumar, N. Patil, S. Husain, C. Chaparro, A. Humar.

Transplant Tolerance: Animal Models II

Room 118-C

2:15pm-2:27pm

CD27low NK Cells Prolong Allograft Survival in Mice By Inhibiting CD8+ T Cell Responses Through Controlling Graft-Derived Donor DCs

A. Kroemer, M. Lantow, E. Eggenhofer, M. Sabet-Baktach, P. Renner, H. Schlitt, E. Geissler.

Concurrent Sessions

4:00pm-5:30pm

Kidney- Delayed Graft Function & Older Age

Room 115-AB

4:48pm-5:00pm

External Validation of Clinical Prediction Models of Patient and Graft Survival in a Canadian Cohort of Kidney Transplant Recipients

S. Singh, D. Naimark, J. Victor, J. Kim.

Linking Innate and Adaptive Alloimmune Responses

Room 118-C

4:36pm-4:48pm

Innate Immune Memory to Allogeneic Non-Self

H. Dai, A. Williams, M. Oberbarnscheidt, F. Lakkis (EAB).

Poster Session D

5:30pm-6:30pm

Exhibit Hall E

Abstract number: 5

Fracture Incidence in Adult Kidney Transplant Recipients

K. Naylor, S. Jamal, G. Zou, E. McArthur, N. Lam, W. Leslie, A. Hodsman, J. Kim, G. Knoll, L.-A. Fraser, J. Adachi, A. Garg.

Abstract number: 109

Age-Specific Graft Failure Rates in Pediatric Liver Transplant Recipients

B. Foster, M. Dahhou, X. Zhang, V. Dharnidharka, J. Conway, V. Ng.

Abstract number: 552

Recurrent Cytomegalovirus Infection After Solid Organ Transplant

Y. Natori, A. Humar, S. Husain, C. Rotstein, D. Kumar.

Abstract number: 1109

Mitochondrial Hydrogen Sulphide Donor Molecules Are More Effective Against Hypoxic Injury in Renal Tubular Epithelial Cells

G. Aboalsamh, M. Saha, I. Lobb, J. Grewal, P. Luke, M. Wood, M. Whiteman, A. Sener.

Abstract number: 1279

The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus (EBV) Associated Post-Transplant Lymphoproliferative Disease (PTLD) in Solid Organ Transplant Recipients: A Systematic Review

M. AlDabbagh, M. Gitman, D. Kumar, A. Humar, C. Rotstein, S. Husain.

Abstract number: 1841

Listing for Liver Transplantation of Patients With Hepatocellular Carcinoma Using the Extended Toronto Criteria; an Intention-to-Treat Analysis

G. Sapisochin, N. Goldaracena, J. Laurence, A. Barbas, M. Dib, A. Ghanekar, M. Selzner, L. Lilly, I. McGilvray, M. Cattral, E. Renner, P. Greig, D. Grant.

#ATC #presentations

18 views
  • Black Facebook Icon
  • Black Twitter Icon
  • Black YouTube Icon

© 2014 by the CDTRP

All rights reserved